Healthcare Scaling Radioligand Remedy: 3 Important Methods From Ins…October 2, 2025 Radioligand therapies have gone mainstream. Eli Lilly’s $1.4 billion acquisition of Level Biopharma and Novartis’s $23 billion U.S. infrastructure funding…
